ConductScience.org, home

Trial · NCT04488367

Blood Loss After Early TXA in Hip Fractures.

NCT04488367, Early phase 1, Unknown, Community Memorial Health System

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Blood Loss After Early TXA in Hip Fractures. Trials, record NCT04488367. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04488367

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Blood Loss After Early TXA in Hip Fractures.
NCT number
NCT04488367
Status
Unknown
Phases
Early phase 1
Enrollment
120 participants, estimated
Lead sponsor
Community Memorial Health System
Conditions
Hip Fractures
Interventions
Tranexamic acid, Normal Saline
First posted
2020-07-28
Last updated
2022-07-19

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in calculated and recorded hemoglobinFrom the time of randomization until discharge from the hospital after initial admission, or 4 weeks, whichever came first.Change in hemoglobin (blood loss) will be assessed based on preoperative blood draw and blood draws post op and on each inpatient day during hospitalization.
PrimaryTotal postoperative units of red blood cell transfusionFrom the time of randomization until discharge from the hospital after initial admission, or 4 weeks, whichever came first.The number of units of RBC transfusions will be recorded and compared between treatment and placebo groups.
SecondaryVTEPostoperative for 30 daysDVT or PE
SecondaryInfectionPostoperative for 30 daysSuperficial and deep infections
SecondaryReadmissionWithin 30 days postoperative30 day readmission
SecondaryOther complicationsPostoperative for 30 daysAny additional unforeseen complications

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers7

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
18349013BACKGROUNDPubMed
20554319BACKGROUNDPubMed
27551568BACKGROUNDPubMed
28031511BACKGROUNDPubMed
28810918BACKGROUNDPubMed
28983887BACKGROUNDPubMed
29426608BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04488367

GET https://conductscience.org/api/trials/v1/NCT04488367/registered